Global Clinical Trial Imaging
Market Report
2025
The Global Clinical Trial Imaging market was valued at USD 985.6 million in 2022 and is projected to reach USD 1,682.6 million by 2030, registering a CAGR of 7.94% for the forecast period 2023-2030.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Clinical Trial Imaging Market Report 2025.
The Global Clinical Trial Imaging market was valued at USD 985.6 million in 2022 and is projected to reach USD 1,682.6 million by 2030, registering a CAGR of 7.94% for the forecast period 2023-2030.
2024 | 2025 | 2032 | 2033 | CAGR | |
---|---|---|---|---|---|
Global Clinical Trial Imaging Market Sales Revenue | 121212 | 121212 | 121212 | 121212 | 7.94% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Product Services |
|
Market Split by End-User |
|
Market Split by Modality |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Clinical Trial Imaging industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Clinical Trial Imaging Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Clinical trial is a process of research studies performed on humans to test developing new drugs. Clinical trials are performed before the commercialization of new drugs and it generates information about safety, efficacy, dose, etc. Clinical trial imaging provides more accurate and effective results about the mechanistic actions of drugs in the body. Clinical trial imaging is a process of image representations of inner body parts for clinical analysis and medical interventions. Clinical trial imaging locates incidental findings which can benefit further clinical evaluation and these findings may result in health benefits and risks. The clinical trial imaging market is predicted to grow owing to increased R&D spending and the growing pharmaceutical and biopharmaceutical industry.
The clinical trial imaging market is predicted to witness remarkable growth over the forecast period owing to increased R&D expenditure by pharmaceutical and biotechnology companies. Government bodies are also investing in healthcare projects to develop new products. Furthermore, the rising number of contract research organizations resulted in the growth of the clinical trial imaging market.
In recent years, many pharmaceutical companies have increased investment in R&D which is expected to propel the market in the near future. For instance, in FY 2022 Johnson & Johnson, one of the leading pharmaceutical companies, invested USD 11,622 million, according to annual reports. Thus, increasing investment in R&D will aid the clinical trial imaging market.
The healthcare industry is growing fast and the cost of healthcare services is also increasing. Image service providers experience challenges to allocate significant capital for investment in high-cost equipment for imaging. The cost of implementation includes purchasing, housing, and maintenance costs of the systems. The cost of imaging systems can range between USD 160,000 to USD 1.6 million. These high costs of purchasing along with maintenance costs will hamper the growth of the clinical trial imaging market.
Clinical trial sector played a vital role in the COVID-19 pandemic in the testing and development of vaccines and other therapeutics. The development of advanced imaging systems helped in better evaluation of CT and radiography images which are used for early diagnosis of COVID-19 disease.
Due to disruption in new research activities, medical studies and clinical trials adversely affected the clinical trial imaging market. The pandemic has held back the ongoing clinical trials and studies. Moreover, situations like lockdown restrictions, disruption in the supply chain, and government regulations, and guidelines adversely impacted the clinical trial imaging market. Besides these impacts, the clinical trial imaging market is expected to bounce back by 2022 owing to a rise in R&D activities.
We have various report editions of Clinical Trial Imaging Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The market for clinical trial imaging market is a moderately competitive market dominated by various major players. Key players are majorly focusing on launching and developing new products. In addition, companies are striving to come up with new strategies such as joint ventures, mergers & acquisitions to expand their footprints across the globe.
Top Companies Market Share in Clinical Trial Imaging Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The clinical trial imaging market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America accounts for the largest share of the market owing to increased funding from the US government to support the healthcare industry. These findings are expected to boost the market by offering the essential infrastructure to expand the area for clinical trials. In addition, the presence of many CROs, increased R&D activities, rising geriatric population, and prevalence of chronic diseases are predicted to drive the market in North America.
The current report Scope analyzes Clinical Trial Imaging Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Clinical Trial Imaging Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Clinical Trial Imaging Industry growth. Clinical Trial Imaging market has been segmented with the help of its Product Services, End-User Modality, and others. Clinical Trial Imaging market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
On the basis of product and service segment, the market is divided into software and services. The service segment is the leading segment of the market and it is expected to grow at the highest CAGR over the forecast period. This growth is due to increased R&D expenditure and the growth of pharmaceutical industries.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Clinical Trial Imaging Industry. Request a Free Sample PDF!
The contract research organizations (CRO) segment holds the largest market share due to snowballing cost of drug development coupled with increased R&D activities. In addition, the surge in demand by pharmaceutical and biotechnology companies for outsourcing research and development to cut down expenses and to get cutting-edge services are boosting the market growth.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Based on modality, the market is segmented into computed tomography, ultrasound, magnetic resonance imaging, etc. Computed tomography holds the largest market share due to the benefits offered by CT such as accurate screening for injuries, cancer tumors, and other abnormalities in the body. In addition, rising investment in clinical studies is driving the market segment growth.
Senior Research Analyst at Cognitive Market Research
Catering to tailored needs of clients in Consulting, Business Intelligence, Market Research, Forecasting, Matrix-Modelling, Data Analytics, Competitive Intelligence, Primary research and Consumer Insights.
Catering to tailored needs of clients in Consulting, Business Intelligence, Market Research, Forecasting, Matrix-Modelling, Data Analytics, Competitive Intelligence, Primary research and Consumer Insights. Experience in analyzing current trends, market demand, market assessment, growth indicators, competitors' strategy, etc. to help top management & investors to make strategic and tactical decisions in the form of market reports and presentations. Successfully delivered more than 500+ client & consulting assignments across verticals. Ability to work independently as well as with a team with confidence and ease.
I am committed to continuous learning and staying at the forefront of emerging trends in research and analytics. Regularly engaging in professional development opportunities, including workshops and conferences, keeps my skill set sharp and up-to-date. I spearheaded research initiatives focused on market trends and competitive landscapes. I have a proven track record of conducting thorough analyses, distilling key insights, and presenting findings in a way that resonates with diverse stakeholders. Through collaboration with cross-functional teams, I played a pivotal role in shaping business strategies rooted in robust research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Clinical Trial Imaging Market is witnessing significant growth in the near future.
In 2023, the Software segment accounted for noticeable share of global Clinical Trial Imaging Market and is projected to experience significant growth in the near future.
The Pharmaceutical Companies segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Bioclinica Inc., Icon PLC and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Product Services | Software, Services |
End-User | Pharmaceutical Companies, Medical Device Manufacturers, Biotechnology Companies, Academic and Government Research Institutes, Contract Research Organizations, Other End-Users |
Modality | Computed Tomography, Ultrasound, Magnetic Resonance Imaging, X-Ray, Positron Emission Tomography, Echocardiography, Other ModalitieS |
List of Competitors | Bioclinica Inc., Parexel International Corporation, Icon PLC, Biomedical Systems Corporation, Biotelemetry Inc., Cardiovascular Imaging Technologies LLC, Intrinsic Imaging LLC, Ixico PLC, Radiant Sage LLC, Worldcare Clinical LLC |
This chapter will help you gain GLOBAL Market Analysis of Clinical Trial Imaging. Further deep in this chapter, you will be able to review Global Clinical Trial Imaging Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Clinical Trial Imaging. Further deep in this chapter, you will be able to review North America Clinical Trial Imaging Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Clinical Trial Imaging. Further deep in this chapter, you will be able to review Europe Clinical Trial Imaging Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Clinical Trial Imaging. Further deep in this chapter, you will be able to review Asia Pacific Clinical Trial Imaging Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Clinical Trial Imaging. Further deep in this chapter, you will be able to review South America Clinical Trial Imaging Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Clinical Trial Imaging. Further deep in this chapter, you will be able to review Middle East Clinical Trial Imaging Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Clinical Trial Imaging. Further deep in this chapter, you will be able to review Middle East Clinical Trial Imaging Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Clinical Trial Imaging. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Services Analysis 2019 -2031, will provide market size split by Product Services. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Services Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End-User Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Modality Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Clinical Trial Imaging market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 14 Research Methodology and Sources
Why Software have a significant impact on Clinical Trial Imaging market? |
What are the key factors affecting the Software and Services of Clinical Trial Imaging Market? |
What is the CAGR/Growth Rate of Pharmaceutical Companies during the forecast period? |
By type, which segment accounted for largest share of the global Clinical Trial Imaging Market? |
Which region is expected to dominate the global Clinical Trial Imaging Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|